56
Growth Score in past quarter
pts
Heat Score 56 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2824178
Canabolabs is an international pharmaceutical company specializing in research and development of medicines.
- Aharon Eyal: Founder
About the Company
Canabolabs is an international pharmaceutical company specializing in research and development of medicines. Canabolabs focuses on development and production of medicines to relieve pain and symptoms that facilitate treatment of various chronic disease and malignant disease.
The company develops medicine and unique dedicated consuming methods,
enabling patients with disabilities that have difficulty using conventional medicine, to consume medicine in a convenient ease while maintaining clinical efficiently. Canabolabs was founded on 2017 and is headquartered in Caesarea, Israel.